Electromed, Inc. balance sheet
At the end of fiscal 2026, Electromed, Inc. had total assets of $66.3m, total liabilities of $12.3m and shareholders' equity of $54.0m. It held $20.4m in cash against $0 of debt.
Balance sheet
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4 | 2 | 1 | 2 | 4 | — | — | — | — | 10 | 12 | 8 | 7 | 16 | 15 | 20 |
| Receivables | 10 | 11 | 9 | 6 | 7 | 8 | 10 | 12 | 13 | 13 | 17 | 21 | 24 | 23 | 25 | 30 |
| Inventory | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 3 | 4 |
| Total current assets | 17 | 16 | 12 | 11 | 13 | 16 | 18 | 23 | 25 | 28 | 32 | 35 | 38 | 44 | 45 | 57 |
| Total assets | 21 | 21 | 18 | 16 | 17 | 21 | 23 | 27 | 29 | 33 | 37 | 41 | 46 | 52 | 54 | 66 |
| Accounts payable | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 |
| Total current liabilities | 4 | 4 | 2 | 2 | 2 | 3 | 3 | 5 | 4 | 3 | 5 | 7 | 8 | 8 | 10 | 12 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — |
| Long-term debt | 2 | 1 | 1 | 1 | 1 | 1 | 1 | — | — | — | — | — | — | — | — | — |
| Total debt | 4 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 6 | 6 | 4 | 3 | 3 | 4 | 4 | 5 | 4 | 3 | 5 | 7 | 8 | 8 | 11 | 12 |
| Shareholders' equity | 15 | 15 | 14 | 13 | 14 | 16 | 20 | 23 | 26 | 30 | 32 | 34 | 38 | 45 | 43 | 54 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | −1 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 8m | 8m | 8m | 8m | 8m | 8m | 8m | 8m | 8m | 9m | 9m | 8m | 9m | 9m | 8m | 8m |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 22 | 23 | 23 | 25 | 25 | 26 | 28 | 30 |
| Inventory | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 4 |
| Total current assets | 41 | 44 | 44 | 45 | 45 | 46 | 50 | 57 |
| Total assets | 49 | 52 | 52 | 54 | 54 | 55 | 59 | 66 |
| Accounts payable | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 |
| Total current liabilities | 7 | 9 | 9 | 10 | 9 | 9 | 10 | 12 |
| Total liabilities | 7 | 9 | 9 | 11 | 9 | 9 | 10 | 12 |
| Shareholders' equity | 41 | 44 | 44 | 43 | 45 | 45 | 49 | 54 |
| Shares outstanding | 8m | 9m | 9m | 8m | 8m | 8m | 8m | 8m |
Compare with peers
- Avita Medical, Inc. balance sheet
- PRO DEX Inc balance sheet
- Tela Bio, Inc. balance sheet
- Sight Sciences, Inc. balance sheet
- Pulmonx Corp balance sheet
Head to head: ELMD vs RCELELMD vs PDEXELMD vs TELA
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies